The global injectable drug delivery market is anticipated to grow at a significant CAGR of 12.8% during the forecast period. The major factor driving the growth of the global injectable drug delivery market is the rising prevalence and incidence of chronic diseases such as diabetes, hormonal disorder, reproductive health issue, and other major diseases. According to the Centers for Disease Control and Prevention (CDC), around 129 million (51.8%) non-institutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. Additionally, 24.6% (61 million) of adults had 1 chronic condition, and 27.2% (68 million) had equal or more than 2 chronic conditions. Furthermore, as per American Action Forum, the total cost of chronic disease in the US reaches $3.7 trillion each year which is almost 19.6% of the country’s gross domestic product (GDP). Additionally, the rising demand for generic injectables and biosimilar as well as rapid technological advancements in the field of injectable drug delivery will offer lucrative growth opportunities for the market during the forecast period.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/injectable-drug-delivery-market
Impact of COVID-19 Pandemic on Global Injectable Drug Delivery Market
During COVID-19, as of May 2020, 212 countries had been impacted by the pandemic, and the governments of these countries had ordered nationwide lockdowns which shut down operations of various industries. Additionally, the global injectable drug delivery market was also impacted by the COVID-19 pandemic due to the operational and logistic challenges faced by the market players due to lockdowns. However, the surge in the rising number of patients due to COVID-19 infection tremendously increased the demand for injectable drug delivery which presented lucrative growth opportunities for the growth of the market during the COVID-19 pandemic.
North America Region Holds a Prominent Share in the Global Injectable Drug Delivery Market
The North American region holds a prominent share in the injectable drug delivery market. The major factor driving the growth of the market in the region is the robust healthcare infrastructure as well as the increasing geriatric population in the region. According to the ACL Administration for Community Living, there were 54.1 million people age 65 and older in the US which represented 16% of the population, more than one in every seven Americans.
by Mode of Administration (Oral and Pulmonary),
by Usability (Reusable and Disposable), and
by End-User (Hospitals & Clinics, Home Care Settings, and Other)
Market Players Outlook
The major companies serving the global injectable drug delivery market include Becton, Dickinson and Co., Baxter International Inc., Eli Lilly and Co., GlaxoSmithKline PLC, and copyright Inc., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, and geographical expansion, to stay competitive in the market. For instance, in July 2019, Neuro Pharma GmbH announced to D-MINE pump for patients with Parkinson’s disease. The device delivers constant subcutaneous drug delivery and is appropriate for use of the patient.
The Report Covers
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global injectable drug delivery market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.
Inquire for Discount on this Report at
https://www.omrglobal.com/report-customization/injectable-drug-delivery-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404